First professional · Los Angeles, California

Is Pharmacy, Pharmaceutical Sciences, and Administration at University of Southern California worth it?

High confidence High confidence: 100+ graduates behind the earnings figures.

The verdict · all families, in-state, half paid with loans

Pays back in time: graduates typically recover the cost in about 5.6 years.

Earnings 1 year after graduating: $119,688; Treasury AY2020-21, AY2021-22 pooled earnings cohort measured in CY2022, CY2023, inflation adjusted to 2024 dollars
Earnings 4 years after graduating: $175,931; Treasury AY2017-2018, AY2018-2019 pooled earnings cohort measured in CY2022, CY2023, inflation adjusted to 2024 dollars
Typical federal debt at graduation: $271,770; NSLDS pooled AY2022-23, AY2023-24 cohort
Typical borrowing (no graduate net price is published): $288k (likely $288k – $288k); AcadYr 2024-25, reported in IPEDS DCY2025-26
Earnings bump, year 4: $107k a year vs bachelor's graduates 4 years out in CA; 2023 ACS 5-year pooled, adjusted to 2024 dollars
Payback: 5.6 years (likely 4.9–6.3); Bump vs net cost plus loan interest
10-year net return: $218k (likely $89k – $350k); Today's dollars
20-year net return: $1.47M (likely $1.17M – $1.82M); Today's dollars
Borrowers making progress / in default, 2 years in: not reported / ≤ 5%; NSLDS AY2016-17, AY2017-18 pooled cohorts measured in 2018-19, 2019-20

Scorecard reports no net price for graduate programs; cost is based on what graduates typically borrowed.